HUMAN GENE ASSOCIATED WITH DIABETIC RETINOPATHY

The disclosed invention relates, in part, to the discovery of a role for the Lipoma HMGIC fusion partner-like 3 (LHFPL3) gene/protein in diabetic retinopathy. Disclosed are methods and compositions related to diagnosing, detecting and treating this disease and other diseases associated with diabetes...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PAQUIN, BRUNO, BRADLEY, WALTER, EDWARD, CLARK, RAELSON, JOHN VERNER, DUBOIS, DANIEL, HENDERSON, NATALI ANNE, PAQUIN, NOUZHA, LITTLE, RANDALL, DAVID, BELOUCHI, ABDELMAJID
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The disclosed invention relates, in part, to the discovery of a role for the Lipoma HMGIC fusion partner-like 3 (LHFPL3) gene/protein in diabetic retinopathy. Disclosed are methods and compositions related to diagnosing, detecting and treating this disease and other diseases associated with diabetes such as diabetic neuropathy. L'invention concerne, en partie, le rôle joué en rétinopathie diabétique par une protéine/un gène de type partenaire de fusion 3 HMGIC de lipome (LHFPL3). Cette invention a également pour objet des méthodes et des compositions concernant le diagnostic, la détection et le traitement de cette maladie et d'autres maladies liées aux diabètes, comme la neuropathie diabétique.